about
NMR investigation of the spontaneous thermal- and/or photoinduced reduction of trans dihydroxido Pt(IV) derivatives.Anthracene-terpyridine metal complexes as new G-quadruplex DNA binders.Functionalized nonporous silica nanoparticles as carriers for Pt(iv) anticancer prodrugs.Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs.Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs.Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs.Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: how long the organic chain should be?trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells.The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells.Synthesis and biological studies of pyrazolyl-diamine Pt(II) complexes containing polyaromatic DNA-binding groups.Revisiting [PtCl₂(cis-1,4-DACH)]: an underestimated antitumor drug with potential application to the treatment of oxaliplatin-refractory colorectal cancer.Synthesis and in vitro cytotoxicity of cis,cis,trans-diamminedichloridodisuccinatoplatinum(IV)-peptide bioconjugates.Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin.Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies.Synthesis, characterization, structure, molecular modeling studies and biological activity of sterically crowded Pt(II) complexes containing bis(imidazole) ligands.Biological activity of enantiomeric complexes [PtCl(2)L (2)] (L (2) is aromatic bisphosphanes and aromatic diamines).The relevance of polar surface area (PSA) in rationalizing biological properties of several cis-diamminemalonatoplatinum(II) derivatives.Prediction of logP for Pt(II) and Pt(IV) complexes: Comparison of statistical and quantum-chemistry based approaches.Enhancement of the cytotoxicity of titanocene dichloride by aging in organic co-solvent.Water-soluble benzoheterocycle triosmium clusters as potential inhibitors of telomerase enzyme.Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes.DNA-metallodrugs interactions signaled by electrochemical biosensors: an overview.Oxidative degradation of 1,5-naphthalenedisulfonic acid in aqueous solutions by UV-photolysis in the absence and presence of H2O2.Electroassisted methods for waste destruction: silver(II) and peroxydisulfate reagents in the electrochemically mediated oxidation of polyaromatic sulfonates.An experiment in the electrokinetic removal of copper from soil contaminated by the brass industry.Oxidative degradation of 1,5-naphthalenedisulfonic acid in aqueous solutions by microwave irradiation in the presence of H2O2.Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuCl(4)(DMSO)(Im)] (NAMI-A) with proteins and the weak interaction with nucleobases.How to obtain Pt(iv) complexes suitable for conjugation to nanovectors from the oxidation of [PtCl(terpyridine)].Molecular interaction fields vs. quantum-mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes.HPLC-MSn to investigate the oxidative destruction pathway of aromatic sulfonate wastes.Tuning photophysical properties with ancillary ligands in Ru(II) mono-diimine complexes.Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what?An unsymmetric cisplatin-based Pt(iv) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate.Electrochemical biosensor evaluation of the interaction between DNA and metallo-drugs.May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs?Study of the synthesis, antiproliferative properties, and interaction with DNA and polynucleotides of cisplatin-like Pt(II) complexes containing carcinogenic polyaromatic amines.Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes.Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure–activity relationship modelingHybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug
P50
Q30589164-9ACA7B5F-098F-467E-81B0-32A871680D24Q38292191-F58AB0C0-B2A4-4AB8-A822-D5405F52DDB7Q38734711-789390A4-DF55-4096-9BAF-0CD2C5A6BE87Q38791841-E22C0210-449E-4B44-A0F8-2159B0ED4439Q38843429-19C04145-0A45-4F7A-ADE4-DB1D66C3D938Q38867690-9E7D73FC-ABC9-44A7-A07A-3B5BDC8C205EQ38961699-5CA381C9-5318-4DC6-BB8C-9D3BA51620C9Q39006039-9DFFD82D-2A39-42EB-9A42-C609DD4F0CC5Q39089791-8B659B99-B2C0-47DC-814C-897A6174ED34Q39093077-027DE308-F5A6-4A42-8543-9FEC8BE523FCQ39265471-DC6D901D-467D-43E4-94C4-946931825DA2Q39315864-0252733D-949E-462D-80F4-E122314ED5D6Q39400663-D28314B1-13F4-4316-ACEC-AFAD8C9B23EFQ39404847-0D3FC0B3-8498-4CE1-9C69-636278D630EBQ39554731-02C5538D-1AB4-477F-9633-2DAD272D1F7DQ39573364-96D7FBB5-08B3-4D3A-80A7-39196AB6B377Q39723723-25128CD9-5600-49AD-9E4A-4111EC29B012Q39819988-177FE457-0F90-49BB-B76E-CA961AA2C81FQ40158652-4B011D73-27EB-4DA8-8121-CA6BF46E790EQ40364901-8A16CD39-03ED-46C6-BD1F-B1DA66A814BEQ40476748-7FE37C58-788C-43E7-B766-7FB6A113B8C3Q41429967-58997CAA-4212-4EB6-B804-F5FCCC81D1F0Q41823463-CF5712B5-8C42-4BE7-A119-C37456B27E5BQ43166943-2463CB67-4D80-40CA-800B-B36C33002DCDQ43315694-37ADF198-37AA-418A-BCB0-59A2422DAD1EQ43329204-0F871FA0-9A84-4428-B7A3-2E79FF2AB654Q43366966-D138BA0E-F560-4E60-AD3E-129E7BE3E3F3Q44900841-88BA7044-8AC4-4DE5-B3AD-43894AE9E520Q46331768-8B3777BA-FD50-4018-88B5-619822D35D89Q46569102-896F9B71-F03A-4A2A-9DFF-9A946339901DQ46794905-603853E6-2E72-49CA-BEAB-666E01FA526DQ47106411-AD614C23-8EF8-4F77-8307-AFC066AF2424Q48350344-32A71B03-194C-4AD1-9A94-BB78C91197FBQ49563999-7B6AD091-84D7-4654-B3AA-CCA03FDD5E68Q51164203-FCA547C6-FB13-41F5-8BF1-B806BC5E9BADQ51297597-FAE2C428-355A-47FD-A8F1-2A934CB86506Q53251531-E0A72B19-69FF-4D8B-BD34-9678C40BA4F1Q53450886-400CE486-E471-4CA3-BAF9-330736E8B3E0Q57819324-D7C429FE-03F7-4044-AB4E-4FC6D6422D6EQ58006792-1359759A-22C0-4DC6-A719-12591F9F56F9
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mauro Ravera
@ast
Mauro Ravera
@en
Mauro Ravera
@es
Mauro Ravera
@nl
Mauro Ravera
@sl
type
label
Mauro Ravera
@ast
Mauro Ravera
@en
Mauro Ravera
@es
Mauro Ravera
@nl
Mauro Ravera
@sl
prefLabel
Mauro Ravera
@ast
Mauro Ravera
@en
Mauro Ravera
@es
Mauro Ravera
@nl
Mauro Ravera
@sl
P1053
F-3068-2016
P106
P1153
7004992034
P21
P31
P3829
P496
0000-0002-4732-7508